BSX Boston Scientific Corp

  1. Stocks
  2. Healthcare
  3. NYSE: BSX

Price (delayed)

$42.67

Market cap

$60.47B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.08

Enterprise value

$67.88B

Sector: Healthcare
Industry: Medical Devices
Website: https://www.bostonscientific.com/

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, ...

Highlights

The equity has grown by 10% YoY
Boston Scientific's debt has decreased by 9% YoY and by 2.1% QoQ
BSX's quick ratio has surged by 112% year-on-year but it is down by 19% since the previous quarter
The EPS has plunged by 103% from the previous quarter and by 102% YoY
Boston Scientific's net income has shrunk by 102% QoQ and by 102% YoY

Key stats

What are the main financial stats of BSX
Market
Shares outstanding
1.42B
Market cap
$60.47B
Enterprise value
$67.88B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.99
Price to sales (P/S)
6.1
EV/EBIT
241.56
EV/EBITDA
48.35
EV/Sales
6.85
Earnings
Revenue
$9.91B
EBIT
$281M
EBITDA
$1.4B
Free cash flow
$1.23B
Per share
EPS
-$0.08
Free cash flow per share
$0.87
Book value per share
$10.7
Revenue per share
$7
TBVPS
$10.52
Balance sheet
Total assets
$30.78B
Total liabilities
$15.45B
Debt
$9.14B
Equity
$15.33B
Working capital
$3.01B
Liquidity
Debt to equity
0.6
Current ratio
1.82
Quick ratio
0.89
Net debt/EBITDA
5.28
Margins
EBITDA margin
14.2%
Gross margin
65%
Net margin
-0.8%
Operating margin
-0.8%
Efficiency
Return on assets
-0.4%
Return on equity
-0.8%
Return on invested capital
1.5%
Return on capital employed
1%
Return on sales
2.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BSX stock price

How has the Boston Scientific stock price performed over time
Intraday
0.23%
1 week
4.3%
1 month
14.58%
1 year
17.23%
YTD
18.69%
QTD
10.4%

Financial performance

How have Boston Scientific's revenue and profit performed over time
Revenue
$9.91B
Gross profit
$6.45B
Operating income
-$79M
Net income
-$82M
Gross margin
65%
Net margin
-0.8%
BSX's operating margin has dropped by 200% since the previous quarter and by 106% year-on-year
Boston Scientific's operating income has plunged by 199% from the previous quarter and by 105% YoY
Boston Scientific's net margin has shrunk by 102% QoQ and by 102% YoY
Boston Scientific's net income has shrunk by 102% QoQ and by 102% YoY

Growth

What is Boston Scientific's growth rate over time

Valuation

What is Boston Scientific stock price valuation
P/E
N/A
P/B
3.99
P/S
6.1
EV/EBIT
241.56
EV/EBITDA
48.35
EV/Sales
6.85
The EPS has plunged by 103% from the previous quarter and by 102% YoY
The stock's price to book (P/B) is 21% more than its last 4 quarters average of 3.3 but 19% less than its 5-year quarterly average of 4.9
The equity has grown by 10% YoY
BSX's P/S is 29% above its 5-year quarterly average of 4.7 and 24% above its last 4 quarters average of 4.9
The revenue has decreased by 8% YoY

Efficiency

How efficient is Boston Scientific business performance
The return on equity has dropped by 103% since the previous quarter and by 102% year-on-year
The return on assets has dropped by 103% since the previous quarter and by 102% year-on-year
BSX's ROIC has plunged by 81% YoY
The ROS has plunged by 74% YoY

Dividends

What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BSX.

Financial health

How did Boston Scientific financials performed over time
Boston Scientific's total assets is 99% more than its total liabilities
BSX's quick ratio has surged by 112% year-on-year but it is down by 19% since the previous quarter
BSX's current ratio has surged by 88% year-on-year but it is down by 2.7% since the previous quarter
Boston Scientific's debt is 40% lower than its equity
Boston Scientific's debt to equity has decreased by 17% YoY
The equity has grown by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.